lathosterol has been researched along with Hyperlipoproteinemia Type II in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 11 (50.00) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baila-Rueda, L; Cenarro, A; Civeira, F; Cofán, M; Mateo-Gallego, R; Perez-Calahorra, S; Puzo, J; Ros, E | 1 |
| Groen, AK; Hutten, BA; Jakulj, L; Kastelein, JJ; Lutjohann, D; Veltri, EP; Vissers, MN | 1 |
| Arca, M; Averna, M; Barraco, G; Cefalù, AB; Fayer, F; Martino, E; Martino, F; Minà, M; Montali, A; Noto, D | 1 |
| Gylling, H; Ketomäki, A; Miettinen, TA; Siimes, MA; Vuorio, A | 1 |
| Gylling, H; Ketomaki, A; Miettinen, TA | 1 |
| Antikainen, M; Gylling, H; Hedman, M; Ketomäki, A; Miettinen, TA | 1 |
| Fricke, CB; Knudsen, I; Lütjohann, D; Mortensen, A; Poulsen, M; Schrøder, M; von Bergmann, K; Wester, I | 1 |
| Jakober, B; Klass, C; Knisel, W; Naoumova, RP; Pfohl, M; Risler, T; Thompson, GR | 1 |
| Ball, M; Chisholm, A; Sutherland, W | 1 |
| Hasler-Rapacz, J; Kempen, HJ; Kudchodkar, BJ; Lacko, A; Princen, HM; Rapacz, J | 1 |
| Colette, C; Crastes De Paulet, A; Descomps, B; Farnier, M; Feillet, C; Monnier, LH; Percheron, C | 1 |
| Braesen, JH; Gebhardt, A; Harsch, M; Lang, G; Löser, R; Niendorf, A; Reymann, A; Schliack, M | 1 |
| Angelin, B; Carlson, LA; Eriksson, M; Miettinen, TA | 1 |
| Ebeling, T; Happonen, P; Miettinen, TA; Pyörälä, K; Turtola, H; Uusitupa, MI; Voutilainen, E | 1 |
| Miettinen, TA; Vanhanen, H | 1 |
| Kesäniemi, YA; Miettinen, TA; Vanhanen, H | 1 |
| Angelin, B; Berglund, L; Dallner, G; Elmberger, PG; Eriksson, M; Kalén, A; Lund, E; Reihnér, E | 1 |
| de Knijff, P; Gevers Leuven, JA; Havekes, L; Kempen, HJ; van der Voort, HA | 1 |
| Gylling, H; Kuusi, T; Miettinen, TA; Vanhanen, H | 1 |
| Gevers Leuven, JA; Glatz, JF; Katan, MB; Kempen, HJ; van der Voort, HA | 1 |
| Koivisto, PV; Miettinen, TA | 2 |
6 trial(s) available for lathosterol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Intestinal Absorption; Male; Middle Aged; Phytosterols; Simvastatin; Sitosterols; Statistics as Topic | 2010 |
Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
Topics: Adolescent; Anticholesteremic Agents; Child; Cholestanol; Cholesterol; Desmosterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2006 |
Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.
Topics: Adult; Blood Component Removal; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Mevalonic Acid; Middle Aged | 1994 |
The effect of dietary fat content on plasma noncholesterol sterol concentrations in patients with familial hypercholesterolemia treated with simvastatin.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin; Sterols | 1994 |
Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Liver; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Simvastatin; Treatment Outcome; Triglycerides | 1995 |
Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.
Topics: Adult; Cholesterol; Cholestyramine Resin; Dietary Fiber; Female; Galactans; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Mannans; Middle Aged; Plant Gums; Sterols | 1992 |
16 other study(ies) available for lathosterol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia.
Topics: Adult; Body Mass Index; Cholesterol; Cholesterol, HDL; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Linear Models; Male; Middle Aged; Overweight; Triglycerides; Weight Loss | 2014 |
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Cholesterol; Discriminant Analysis; Female; Gas Chromatography-Mass Spectrometry; Genetic Predisposition to Disease; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Italy; Male; Multifactorial Inheritance; Phytosterols; Predictive Value of Tests; Sitosterols; Sterols | 2010 |
Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia.
Topics: Adolescent; Apolipoproteins E; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Phenotype; Phytosterols; Squalene | 2003 |
Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
Topics: Adult; Blood Component Removal; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Fats; Double-Blind Method; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Margarine; Middle Aged; Phytosterols; Sitosterols; Squalene; Triglycerides | 2004 |
Increased plant sterol and stanol levels in brain of Watanabe rabbits fed rapeseed oil derived plant sterol or stanol esters.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Blood-Brain Barrier; Brain; Cholesterol; Disease Models, Animal; Fatty Acids, Monounsaturated; Female; Heterozygote; Homozygote; Hyperlipoproteinemia Type II; Liver; Male; Phytosterols; Plant Oils; Rabbits; Rapeseed Oil; Sitosterols | 2007 |
Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
Topics: Animals; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Enzyme Inhibitors; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Male; Swine; Swine Diseases; Triglycerides | 1996 |
Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Heterozygote; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Immunohistochemistry; Intestinal Absorption; Liver; Phytosterols; Polymerase Chain Reaction; Pravastatin; Rabbits; Receptors, LDL; RNA, Messenger | 1998 |
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Arteriosclerosis; Bile Acids and Salts; Biological Transport; Biomarkers; Cholesterol; Cholesterol, HDL; Coronary Artery Disease; Drug Evaluation; Feces; Heterozygote; Humans; Hyperlipoproteinemia Type II; Infusions, Intravenous; Liposomes; Liver; Male; Middle Aged; Phospholipids; Protein Precursors; Recombinant Fusion Proteins; Sterols | 1999 |
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Desmosterol; Female; Humans; Hyperlipoproteinemia Type II; Isomerism; Lovastatin; Male; Middle Aged; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 1992 |
Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man.
Topics: Adult; Cholesterol; Feces; Female; Humans; Hyperlipoproteinemia Type II; Ileum; Intestinal Absorption; Male; Middle Aged; Pravastatin; Steroids; Sterols | 1992 |
Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Dolichols; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Mevalonic Acid; Middle Aged; Pravastatin; Ubiquinone | 1991 |
Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia.
Topics: Analysis of Variance; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Isomerism; Phenotype; Phytosterols; Sitosterols | 1991 |
Apolipoprotein E phenotype and cholesterol metabolism in familial hypercholesterolemia.
Topics: Apolipoproteins E; Cholesterol; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Phenotype; Sitosterols | 1989 |
Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans.
Topics: Anticholesteremic Agents; Biomarkers; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Isomerism; Lovastatin; Male; Simvastatin | 1988 |
Evaluation of bile acid malabsorption by plasma cholesterol precursor sterols in familial hypercholesterolaemia patients with and without ileal exclusion.
Topics: Adult; Bile Acids and Salts; Cholestadienols; Cholestenes; Cholesterol; Desmosterol; Feces; Female; Humans; Hyperlipoproteinemia Type II; Ileum; Lanosterol; Male; Middle Aged; Squalene | 1988 |
Biliary lathosterol and other cholesterol precursor sterols are increased in patients with ileal exclusion.
Topics: Bile; Cholestenes; Cholesterol; Desmosterol; Female; Humans; Hyperlipoproteinemia Type II; Ileum; Lanosterol; Male; Middle Aged | 1988 |